SOLACI-CACI 2024 – Day 1 Presentations

Discover the highlights of the first day of activities of SOLACICACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires, Argentina. 

  • Dr. Mauricio Cohen (USA) – “How to start a CHIP program?”
  • Dr. Augusto Pichard (USA) – “Current Strategies for Percutaneous Treatment of SVG Disease in ACS”
  • Dra. Alaide Chieffo (ITA) – “Analysis of post-stent coronary dissections, when we should treat it”
  • Dr. George Dangas (USA) – “Is there a role for thrombus aspiration in PCI?”
  • Dr. Roxana Mehran (USA) – “Anti-platelet treatment in AMI and Inflammation”
  • Dr. Daniel Berrocal (ARG) – “PCI in Patient with Symptomatic Chronic Coronary Syndrome”
  • Dr. Daniel Aguirre (CHL) – “Required Credentials for an Interventional Cardiologist to Intervene in Adult Congenital Heart Disease”
  • Dra. Tieta Albanez (BRA) – “Current Status of LMCA PCI: Contributions From Clinical Studies”
  • Dr. Mario Araya (CHL) – “Dissections: what we should and should not leave”
  • Dr. Ricardo Costa (BRA) – “Understand the concepts, techniques, and devices to achieve optimal vessel preparation for the perfect DEB outcome-DEB technology in de novo coronary lesions”
  • Dr. Juan Ignacio Damonte (ARG) – “Barriers and oportunities in the decision -making process for a Cardiology subespeciality”
  • Dr. Anibal Damonte (ARG) – “LAAO: What´ s the best management of peridevice leak?”
  • Dr. George Dangas (USA) – “TAVR and Coronary artery disease”
  • Dr. Diego Guzzanti (ARG) – “Deep Vein Thrombosis: Treatment. Pharmacoinvasive Treatment and Percutaneous Thrombectomy”
  • Dr. Pablo Mascolo (ARG) – “When do we consider a lesion to be non-obstructive: by angiography or angioCT”
  • Dr. Ricardo Lluberas (UY) – “Multivessel Disease: Is Complete Revascularization Necessary in Fragile Adult Patients?”
  • Dr. José Martín Rabellino (ARG) – “Surgery for TAVI failure: what do we know about device explantation?”
  • Dr. Evandro Martins (BRA) – “The post-CABG CTO challenge”
  • Dr. Matías Rodríguez Granillo (ARG) – “Patient with Coronary Disease and Diabetes”
  • Dr. Sebastián Mrad (ARG) – “Mentoring as a Tool to Optimize Decision-Making During a Medical Career”

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...